Permanent His bundle pacing using a Biotronik stylet-driven Lead: feasibility and early outcomes from a single centre
Brian Vezi1, Ajijola Olujimi2, Marcus Ngatcha3
1Busamed Gateway Private Hospital, Umhlanga, South Africa.
Cardiovascular Journal of Africa
|October 14, 2022
Summary
His bundle pacing (HBP) offers an alternative to cardiac resynchronisation therapy (CRT). Early African experience shows HBP is feasible and reliable for various pacing needs.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- His bundle pacing (HBP) is an alternative to cardiac resynchronisation therapy (CRT), potentially benefiting patients with CRT response deficits.
- HBP requires precise His bundle lead placement, posing a technical challenge.
Observation:
- This case series reports the initial experience in Africa using specific Biotronik pacing leads and introducer guides for HBP.
- The study included patients with complete heart block, pre-existing right ventricular pacing, and heart failure with left bundle branch block.
Findings:
- The Biotronik Solia pacing lead and Selectra 3D introducer guide demonstrated feasibility and reliability for HBP implantation.
- Appropriate programming and conduction system assessment are crucial for predicting HBP benefits and potential additional left ventricular lead implantation.
Implications:
- This study highlights the successful application of HBP in diverse patient populations in an African setting.
- The findings suggest that conduction system pacing tools can achieve good acute outcomes, expanding HBP accessibility.
